PPD wins Brazilian bioanalytical signoff; Report: Indian man jumps off building to escape clinical trial;

> After some back and forth, India reportedly has a plan to comply with the EU's regulations on API imports. Article

> CRO Veristat played an important role in Aegerion Pharmaceuticals' recent FDA approval of Juxtapid, a drug for high cholesterol. More

> PPD has won a Brazilian signoff to conduct bioanalytical tests at its operations within the country. News

> The European CRO Federation is calling for clarity in the EU's proposed regulations on post-authorization efficacy studies, wondering when they'd be voluntary versus when the tests would be required. Story

> French CMO Indica has bought Biotechnologie Appliquee to boost its ready-to-use media manufacturing. Item

> According to The Times of India, a man in Hyderabad jumped from a building to escape a clinical trial when "a prominent pharmaceutical firm" refused to let him change his mind about the study. Report

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.